DOC monthly performance report
Monthly DOC research: returns, drawdown, relative strength, seasonality, and key stats.
DOC monthly report
—
Key takeaways
- Healthpeak Properties (DOC) closed September 2026 at $20.37, down 2.16% for the month and +12.67% over the trailing 12 months.
- Year-to-date, DOC is +26.68%, outperforming the S&P 500 which has returned +11.58% YTD.
- The stock is trading +9.37% versus its 200-day moving average ($18.63), a bullish technical signal.
- Over the past three years, DOC has underperformed the S&P 500 by −68.95%, with a relative strength index reading of 59.2.
- Win rate over the trailing 39 months stands at 46.2% — 18 positive months versus 21 negative months.
Healthpeak Properties ended September 2026 at $20.37, posting a monthly return of −2.16%. The S&P 500 returned −0.80% over the same window, leaving relative performance at −1.36%.
The current quarter stands at −4.81% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +9.37% versus the 200-day moving average ($18.63).
Year-to-date, DOC is +26.68% against SPY +11.58%, a gap of +15.10%. The stock is currently −11.24% below its 52-week high, with maximum 3-year drawdown at −31.75%.
| Period | DOC | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +0.34% | −0.45% | +0.79% |
| 1 Week | −1.36% | −1.21% | −0.15% |
| 1 Month | −2.16% | −0.80% | −1.36% |
| 3 Months | −0.49% | +3.13% | −3.62% |
| 6 Months | +16.93% | +12.36% | +4.57% |
| YTD | +26.68% | +11.58% | +15.10% |
| 12 Months | +12.67% | +15.74% | −3.07% |
| 3 Years | 0.00% | +68.95% | −68.95% |
| Rank | Month | Return |
|---|---|---|
| #1 | May 2026 | +18.43% |
| #2 | Dec 2023 | +14.32% |
| #3 | Mar 2024 | +11.94% |
| #4 | Jun 2026 | +11.75% |
| #5 | Nov 2023 | +11.38% |
| Rank | Month | Return |
|---|---|---|
| #1 | Oct 2023 | −15.31% |
| #2 | Dec 2025 | −11.94% |
| #3 | Apr 2025 | −11.77% |
| #4 | Sep 2023 | −10.79% |
| #5 | Feb 2024 | −9.46% |
| Quarter | Return |
|---|---|
| Q2 2025 | −13.40% |
| Q3 2025 | +9.37% |
| Q4 2025 | −16.03% |
| Q1 2026 | +2.18% |
| Q2 2026 | +30.25% |
| Q3 2026 (QTD) | −4.81% |
| Year | Return |
|---|---|
| 2023 | −21.02% |
| 2024 | +2.37% |
| 2025 | −20.67% |
| 2026 | +26.68% |
| Metric | Value |
|---|---|
| 52-Week High | $22.95 (2026-07-28) |
| 52-Week Low | $15.71 (2025-12-23) |
| Current Price | $20.37 |
| 200-Day Moving Average | $18.63 |
| Price vs 200DMA | +9.37% |
| 3-Year Maximum Drawdown | −31.75% (2025-12-23) |
| Current Drawdown from 52W High | −11.24% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 59.2 |
| 3-Year Excess Return vs S&P 500 | −68.95% |
| RS Peak | 101.7 (Sep 2023) |
| RS Trough | 49.7 (Apr 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was DOC's return for this report period?
DOC returned −2.16% in the latest monthly window ending 2026-09-14.
Has DOC outperformed SPY year to date?
YTD DOC: +26.68% vs SPY: +11.58%.
What is DOC's 12-month return?
+12.67% over the trailing 12 months.
Is DOC above or below its 200-day moving average?
Price is +9.37% versus 200DMA ($18.63).
What is the maximum drawdown in the 3-year window?
−31.75% on 2025-12-23.